An increasing number of Chinese pharmaceutical companies, in particular privately-owned firms in coastal areas, are eyeing the international market.

Chinese pharmaceutical companies are seeing more anti-dumping or anti-subsidy cases. The conflicts are spreading to some major exports.

Domestic companies are working to counteract the on-going dumping claims. They understand that they might totally lose the target market if they do not respond.

This one is privately owned.

The Swiss are much smarter than American pharmaceutical firms.

There are a number of different reasons why. The main one is that Chinese telecommunications companies don't have enough bandwidth to interact with the outside world.